This page contains research articles and infographics pertaining to cannabis-related impairment. It is important to understand the risk of cognitive and psychomotor impairment associated with THC dose. The papers provided address the cognitive impacts on performance, duration of impairment, and impaired driving/collision risk associated with cannabis use. The modifiable and non-modifiable factors that influence acute neurocognitive impairment in medical cannabis are provided.
Chapter 36
Cannabinoid-Related Adverse Events and Impairment
Narouze SN, MacCallum CA. eds. Cannabinoids and Pain. Springer; 2021
Systematic Review
Duration of Neurocognitive Impairment with Medical Cannabis Use: A Scoping Review
Frontiers in Psychiatry. 2021
Eadie L… MacCallum CA, et al.
Poster
Duration of Neurocognitive Impairment with Medical Cannabis Use: A Scoping Review
Canadian Public Health Association. 2021
Lo L… MacCallum CA, et al.
Infographic
Modifiable and Non-Modifiable Factors Influencing Acute Neurocognitive Impairment in Medical Cannabis Users
© Dr. Caroline MacCallum 2021
Short-term effects of cannabis consumption on cognitive performance in medical cannabis patients. Applied Neuropsychology: Adult. 2019
Medical cannabis and impaired driving: preliminary research review. Canadians for Access to Medical Marijuana. 2017
Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biological Psychiatry. 2016; 79(7)
Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012; 344
Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004; 73(2)